165 related articles for article (PubMed ID: 35228063)
1. Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
Li S; Xu W; Wang H; Tang T; Ma J; Cui Z; Shi H; Qin T; Zhou H; Li L; Jiang T; Li C
Biomed Pharmacother; 2022 Apr; 148():112742. PubMed ID: 35228063
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against
Huang M; Cao X; Jiang Y; Shi Y; Ma Y; Hu D; Song X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613672
[No Abstract] [Full Text] [Related]
4. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism.
Cui Z; Wang H; Li S; Qin T; Shi H; Ma J; Li L; Yu G; Jiang T; Li C
J Pharmacol Sci; 2022 Jan; 148(1):73-85. PubMed ID: 34924133
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression.
Wang Z; Li M; Liu Y; Qiao Z; Bai T; Yang L; Liu B
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558645
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
[TBL] [Abstract][Full Text] [Related]
8. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dihydroartemisinin on
Xu W; Wang H; Tang T; Ma J; Cui Z; Li L; Guo S; Zhou Y; Jiang T; Li C
Am J Chin Med; 2019; 47(6):1325-1343. PubMed ID: 31488031
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
[TBL] [Abstract][Full Text] [Related]
11. Probucol dramatically enhances dihydroartemisinin effect in murine malaria.
Kume A; Anh DT; Shichiri M; Ishida N; Suzuki H
Malar J; 2016 Sep; 15():472. PubMed ID: 27634686
[TBL] [Abstract][Full Text] [Related]
12. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.
Yi R; Wang H; Deng C; Wang X; Yao L; Niu W; Fei M; Zhaba W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452511
[TBL] [Abstract][Full Text] [Related]
14. The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer.
Hu Y; Guo N; Yang T; Yan J; Wang W; Li X
Oxid Med Cell Longev; 2022; 2022():1458143. PubMed ID: 35028002
[TBL] [Abstract][Full Text] [Related]
15. pH-dependent rearrangement determines the iron-activation and antitumor activity of artemisinins.
Bai G; Gao Y; Liu S; Shui S; Liu G
Free Radic Biol Med; 2021 Feb; 163():234-242. PubMed ID: 33359684
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells.
Ganguly U; Singh S; Bir A; Ghosh A; Chakrabarti SS; Saini RV; Saso L; Bisaglia M; Chakrabarti S
Free Radic Res; 2024 Mar; 58(3):217-228. PubMed ID: 38572725
[TBL] [Abstract][Full Text] [Related]
18. Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma.
Yangyun W; Guowei S; Shufen S; Jie Y; Rui Y; Yu R
Gene; 2022 Jan; 809():145992. PubMed ID: 34648917
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable iron-coordinated hollow polydopamine nanospheres for dihydroartemisinin delivery and selectively enhanced therapy in tumor cells.
Dong L; Wang C; Zhen W; Jia X; An S; Xu Z; Zhang W; Jiang X
J Mater Chem B; 2019 Oct; 7(40):6172-6180. PubMed ID: 31559402
[TBL] [Abstract][Full Text] [Related]
20. Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin.
Chen L; Zheng Z; Liu H; Wang X; Qu S; Yang Y; Deng S; Zhang Y; Tuo L; Zhao Y; Li Y
Microbiol Spectr; 2021 Dec; 9(3):e0127821. PubMed ID: 34908430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
